Cargando…
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894154/ https://www.ncbi.nlm.nih.gov/pubmed/33146922 http://dx.doi.org/10.1002/ajh.26043 |
| _version_ | 1783653188346314752 |
|---|---|
| author | Zheng, Hong Mineishi, Shin Claxton, David Zhu, Junjia Zhao, Chenchen Jia, Bei Ehmann, W. Christopher Rybka, Witold B. Naik, Seema Songdej, Natthapol Drabick, Joseph J. Hohl, Raymond J. |
| author_facet | Zheng, Hong Mineishi, Shin Claxton, David Zhu, Junjia Zhao, Chenchen Jia, Bei Ehmann, W. Christopher Rybka, Witold B. Naik, Seema Songdej, Natthapol Drabick, Joseph J. Hohl, Raymond J. |
| author_sort | Zheng, Hong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7894154 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78941542021-03-02 A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia Zheng, Hong Mineishi, Shin Claxton, David Zhu, Junjia Zhao, Chenchen Jia, Bei Ehmann, W. Christopher Rybka, Witold B. Naik, Seema Songdej, Natthapol Drabick, Joseph J. Hohl, Raymond J. Am J Hematol Correspondences John Wiley & Sons, Inc. 2020-11-23 2021-02-01 /pmc/articles/PMC7894154/ /pubmed/33146922 http://dx.doi.org/10.1002/ajh.26043 Text en © 2020 The Authors. American Journal of Hematology published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondences Zheng, Hong Mineishi, Shin Claxton, David Zhu, Junjia Zhao, Chenchen Jia, Bei Ehmann, W. Christopher Rybka, Witold B. Naik, Seema Songdej, Natthapol Drabick, Joseph J. Hohl, Raymond J. A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title | A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title_full | A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title_fullStr | A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title_full_unstemmed | A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title_short | A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| title_sort | phase i clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia |
| topic | Correspondences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894154/ https://www.ncbi.nlm.nih.gov/pubmed/33146922 http://dx.doi.org/10.1002/ajh.26043 |
| work_keys_str_mv | AT zhenghong aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT mineishishin aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT claxtondavid aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT zhujunjia aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT zhaochenchen aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT jiabei aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT ehmannwchristopher aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT rybkawitoldb aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT naikseema aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT songdejnatthapol aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT drabickjosephj aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT hohlraymondj aphaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT zhenghong phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT mineishishin phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT claxtondavid phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT zhujunjia phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT zhaochenchen phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT jiabei phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT ehmannwchristopher phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT rybkawitoldb phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT naikseema phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT songdejnatthapol phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT drabickjosephj phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia AT hohlraymondj phaseiclinicaltrialofavelumabincombinationwithdecitabineasfirstlinetreatmentofunfitpatientswithacutemyeloidleukemia |